NovaBridge Biosciences (NBP) — Capital Reinvestment Ratio
NovaBridge Biosciences (NBP) has a Capital Reinvestment Ratio of 0.00x as of September 2025, meaning it reinvests 0% of its operating cash flow ($13.15 Million) in capital expenditures ($41.00). See NovaBridge Biosciences balance sheet quality to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
NovaBridge Biosciences Capital Reinvestment Ratio (2020–2020)
This chart tracks NovaBridge Biosciences's Capital Reinvestment Ratio across 1 annual periods. Check how aggressively does NovaBridge Biosciences reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for NovaBridge Biosciences (2020–2020)
Year-by-year Capital Reinvestment Ratio for NovaBridge Biosciences from 2020 to 2020. For live market cap and broader valuation context, see NovaBridge Biosciences market capitalisation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2020 | 0.02x | $433.56 Million | $8.01 Million | — |